Tempus is a leading provider of AI-enabled precision medicine solutions that harness the power of data and artificial intelligence to revolutionize healthcare. With Tempus, providers, life sciences companies, and patients can access innovative technology that accelerates the discovery of novel targets, predicts treatment effectiveness, identifies clinical trials, and diagnoses diseases earlier.

Key features of Tempus include:

1. **Tempus One**: An AI-enabled clinical assistant that helps clinicians make more informed treatment decisions.
2. **Clinical Trial Matching**: Connects patients with potential clinical trials based on their unique profile.
3. **Multi-omics Sequencing**: Offers whole transcriptome panels that provide insights into clinically relevant fusions and altered splicing.
4. **Real World Data Analysis**: Analyzes multimodal real-world data to assist in clinical decision-making.
5. **Algorithmic Models**: Uses algorithmic models connected to assays to provide additional insights into patient care.

Tempus has established partnerships with over 200 biopharma companies, academic medical centers, and oncologists in the US, demonstrating its widespread adoption in the healthcare industry. The company's commitment to improving patient care is evident through its large clinical data library for cancer research and its focus on precision medicine.

For providers, life sciences companies, and patients looking to leverage the latest advancements in AI-enabled precision medicine, Tempus offers a comprehensive suite of solutions that aim to transform personalized patient care and drive scientific discovery. Visit the Tempus website to learn more about their innovative technology and the impact it is making in healthcare.